252 related articles for article (PubMed ID: 18208813)
1. CD33 detection by immunohistochemistry in paraffin-embedded tissues: a new antibody shows excellent specificity and sensitivity for cells of myelomonocytic lineage.
Hoyer JD; Grogg KL; Hanson CA; Gamez JD; Dogan A
Am J Clin Pathol; 2008 Feb; 129(2):316-23. PubMed ID: 18208813
[TBL] [Abstract][Full Text] [Related]
2. CD163: a specific marker of macrophages in paraffin-embedded tissue samples.
Lau SK; Chu PG; Weiss LM
Am J Clin Pathol; 2004 Nov; 122(5):794-801. PubMed ID: 15491976
[TBL] [Abstract][Full Text] [Related]
3. Anti-CD10 immunoperoxidase staining of paraffin-embedded acute leukemias: comparison with flow cytometric immunophenotyping.
Bavikatty NR; Ross CW; Finn WG; Schnitzer B; Singleton TP
Hum Pathol; 2000 Sep; 31(9):1051-4. PubMed ID: 11014570
[TBL] [Abstract][Full Text] [Related]
4. Leu-M1 antigen as a marker of acute nonlymphoid leukemia.
Chan J; Beckstead JH
Hematol Pathol; 1987; 1(4):209-15. PubMed ID: 2461928
[TBL] [Abstract][Full Text] [Related]
5. CD33 monoclonal antibody conjugated Au cluster nano-bioprobe for targeted flow-cytometric detection of acute myeloid leukaemia.
Retnakumari A; Jayasimhan J; Chandran P; Menon D; Nair S; Mony U; Koyakutty M
Nanotechnology; 2011 Jul; 22(28):285102. PubMed ID: 21654031
[TBL] [Abstract][Full Text] [Related]
6. Myeloid precursors and acute myeloid leukemia cells express multiple CD33-related Siglecs.
Nguyen DH; Ball ED; Varki A
Exp Hematol; 2006 Jun; 34(6):728-35. PubMed ID: 16728277
[TBL] [Abstract][Full Text] [Related]
7. [Immunohistochemical characterization of acute leukemia. Study of 31 bone marrow biopsies].
Rousselet MC; Laniece A; Gardais J; Dautel M; Gardembas-Pain M; Pellier I; Ifrah N; Saint-André JP
Ann Pathol; 1995; 15(2):119-26. PubMed ID: 7538764
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical characterization of mast cell disease in paraffin sections using tryptase, CD68, myeloperoxidase, lysozyme, and CD20 antibodies.
Li WV; Kapadia SB; Sonmez-Alpan E; Swerdlow SH
Mod Pathol; 1996 Oct; 9(10):982-8. PubMed ID: 8902835
[TBL] [Abstract][Full Text] [Related]
9. Anti-CD33 monoclonal antibodies enhance the cytotoxic effects of cytosine arabinoside and idarubicin on acute myeloid leukemia cells through similarities in their signaling pathways.
Balaian L; Ball ED
Exp Hematol; 2005 Feb; 33(2):199-211. PubMed ID: 15676214
[TBL] [Abstract][Full Text] [Related]
10. Surface expression and function of p75/AIRM-1 or CD33 in acute myeloid leukemias: engagement of CD33 induces apoptosis of leukemic cells.
Vitale C; Romagnani C; Puccetti A; Olive D; Costello R; Chiossone L; Pitto A; Bacigalupo A; Moretta L; Mingari MC
Proc Natl Acad Sci U S A; 2001 May; 98(10):5764-9. PubMed ID: 11320212
[TBL] [Abstract][Full Text] [Related]
11. PG-M1: a new monoclonal antibody directed against a fixative-resistant epitope on the macrophage-restricted form of the CD68 molecule.
Falini B; Flenghi L; Pileri S; Gambacorta M; Bigerna B; Durkop H; Eitelbach F; Thiele J; Pacini R; Cavaliere A
Am J Pathol; 1993 May; 142(5):1359-72. PubMed ID: 7684194
[TBL] [Abstract][Full Text] [Related]
12. A new Mel-CAM (CD146)-specific monoclonal antibody, MN-4, on paraffin-embedded tissue.
Shih IM; Nesbit M; Herlyn M; Kurman RJ
Mod Pathol; 1998 Nov; 11(11):1098-106. PubMed ID: 9831208
[TBL] [Abstract][Full Text] [Related]
13. Anti-CD34 immunoperoxidase staining in paraffin sections of acute leukemia: comparison with flow cytometric immunophenotyping.
Hanson CA; Ross CW; Schnitzer B
Hum Pathol; 1992 Jan; 23(1):26-32. PubMed ID: 1371985
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemistry can be used to subtype acute myeloid leukemia in routinely processed bone marrow biopsy specimens. Comparison with flow cytometry.
Manaloor EJ; Neiman RS; Heilman DK; Albitar M; Casey T; Vattuone T; Kotylo P; Orazi A
Am J Clin Pathol; 2000 Jun; 113(6):814-22. PubMed ID: 10874882
[TBL] [Abstract][Full Text] [Related]
15. Immunophenotypic profile of myeloid cells in granulocytic sarcoma by immunohistochemistry. Correlation with blast differentiation in bone marrow.
Chang CC; Eshoa C; Kampalath B; Shidham VB; Perkins S
Am J Clin Pathol; 2000 Nov; 114(5):807-11. PubMed ID: 11068557
[TBL] [Abstract][Full Text] [Related]
16. Myeloperoxidase: a specific marker for myeloid cells in paraffin sections.
Pinkus GS; Pinkus JL
Mod Pathol; 1991 Nov; 4(6):733-41. PubMed ID: 1724087
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the CD33-related siglec family reveals that Siglec-9 is an endocytic receptor expressed on subsets of acute myeloid leukemia cells and absent from normal hematopoietic progenitors.
Biedermann B; Gil D; Bowen DT; Crocker PR
Leuk Res; 2007 Feb; 31(2):211-20. PubMed ID: 16828866
[TBL] [Abstract][Full Text] [Related]
18. The prognostic impact of myeloid antigen expression in pediatric acute lymphoblastic leukemia patients.
Unal S; Cetin M; Tuncer AM; Gümrük F; Yetgin S
Turk J Pediatr; 2008; 50(6):533-6. PubMed ID: 19227415
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of acute myeloid leukemia cell growth by mono-specific and bi-specific anti-CD33 x anti-CD64 antibodies.
Balaian L; Ball ED
Leuk Res; 2004 Aug; 28(8):821-9. PubMed ID: 15203280
[TBL] [Abstract][Full Text] [Related]
20. Expression of an anti-CD33 single-chain antibody by Pichia pastoris.
Emberson LM; Trivett AJ; Blower PJ; Nicholls PJ
J Immunol Methods; 2005 Oct; 305(2):135-51. PubMed ID: 16139294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
